|
summary: This study investigating the behaviour of blood cells from MS patients in an artificial environment found that mitoxantrone, a treatment for severe relapsing MS, may prevent certain inflammatory cells from crossing the blood brain barrier into the central nervous system.
authors: Kopadze T, Dehmel T, Hartung HP, Stuve O, Kieseier BC.
source: Arch Neurol. 2006 Nov;63(11):1572-8.
weblink: click here
category: Clinical Trials and Therapeutics
related research news: click here
glossary:
Brain
Cell
Central nervous system
Immunocompetent
Immunoglobulin
Immunosuppressio
Multiple sclerosis
Nervous system
Sclerosis
T-cell
|
